Statins for asymptomatic middle cerebral artery stenosis: The regression of cerebral artery stenosis study

Cerebrovascular Diseases

Volumn 28, Issue 1, 2009, Pages 18-25

  Mok, Vincent C T ^a   Lam, Wynnie W M ^a   Chen, X Y ^a   Wong, Adrian ^a   Ng, Ping Wing ^b   Tsoi, Tak Hon ^b   Yeung, Vincent ^b   Liu, Roxanna ^a   Soo, Yannie ^a   Leung, T W ^a   Wong, Ka Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Our Lady of Maryknoll Hospital Hong Kong   (Hong Kong)

Author keywords

Middle cerebral artery stenosis progression; Regression of Cerebral Artery Stenosis study; Statins

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PLACEBO; SIMVASTATIN;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

AGED; CONSTRICTION, PATHOLOGIC; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; TREATMENT OUTCOME;

EID: 65449135597     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215939     Document Type: Article

References (26)

1. Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, et al: Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000; 31:2641 -2647.
2. Wong KS, Huang YN, Yang HB, Gao S, Li H, Liu JY, et al: A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 2007;68:2031-2034.
3. Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B: Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007;68:2035-2038.
4. Thomas GN, Chen XY, Lin JW, Tomlinson B, Lam WW, Liu R, et al: Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients. Cerebrovasc Dis 2008;25:261-267.
5. Sabeti S, Schlager O, Exner M, Mlekusch W, Amighi J, Dick P, et al: Progression of carotid stenosis detected by duplex ultrasonogra- phy predicts adverse outcomes in cardiovascular high-risk patients. Stroke 2007; 38: 2887-2894.
6. Waters D, Craven TE, Lesperance J: Prognostic significance of progression of coronary atherosclerosis. Circulation 1993; 87: 1067-1075.
7. Akins PT, Pilgram TK, Cross DT 3rd, Moran CJ: Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998;29:433-438.
8. Wong KS, Li H, Lam WW, Chan YL, Kay R: Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 2002; 33:532-536.
9. Arenillas JF, Molina CA, Montaner J, Abil- leira S, Gonzalez-Sanchez MA, Alvarez-Sa- bin J: Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001; 32:2898-2904.
10. Smilde TJ, van Wissen S, Wollersheim H,Trip MD, Kastelein JJ, Stalenhoef AF: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001;357:577-581.
11. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, et al: Coronary angiographic changes with lo- vastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993;119:969-976.
12. Amarenco P, Labreuche J, Lavallee P, Tou- boul PJ: Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35: 2902-2909.
13. Effect of simvastatin on coronary ather- oma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344:633-638.
14. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, et al: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323: 1289-1298.
15. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
17. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355: 549-559.
18. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al, West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterol- emia. N Engl J Med 1995;333:1301-1307.
19. Wong KS, Lam WW, Liang E, Huang YN, Chan YL, Kay R: Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 1996; 27: 1084-1087.
20. Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, et al: Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.Stroke 2005; 36: 782-786.
21. Bang OY, Saver JL, Liebeskind DS, Pineda S, Ovbiagele B: Association of serum lipid indices with large artery atherosclerotic stroke. Neurology 2008;70:841-847.
22. Arenillas JF, Molina CA, Chacon P, Rovira A, Montaner J, Coscojuela P, et al: High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63: 27-32.
23. Chen XY, Wong KS, Lam WW, Zhao HL, Ng HK: Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis2008;25: 74-80.
24. Kane JP, Malloy MJ, Ports TA, Phillips NR,Diehl JC, Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-3012.
25. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080.
26. Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, et al: The Stroke Outcomes and Neuroimaging of In- tracranial Atherosclerosis (SONIA) trial. Neurology 2007;68:2099-2106.